Resumption of atrioventricular conduction by levosimendan after radiofrequency ablation of the AV node:.
We report the case of a patient in whom radiofrequency catheter ablation of the AV node was initially successfully performed for persistent atrial fibrillation with fast ventricular rate, but in whom atrioventricular conduction transiently resumes following therapy with levosimendan. Plausible hypothesis are discussed as well as potential implications.
Maury
Philippe
P
From the Fédération des Services de Cardiologie, University Hospital Rangueil, Toulouse, France.
Baixas
Cecile
C
Roncalli
Jerome
J
Couderc
Philippe
P
Delay
Marc
M
Pathak
Athul
A
Galinier
Michel
M
D000889:Anti-Arrhythmia Agents / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000628:therapy*; D001283:Atrioventricular Node / Q000254:growth & development / Q000601:surgery*; D002037:Bundle-Branch Block / Q000628:therapy; D002316:Cardiotonic Agents / Q000627:therapeutic use*; D017115:Catheter Ablation; D006327:Heart Block / Q000188:drug therapy*; D006333:Heart Failure / Q000150:complications; D006801:Humans; D006835:Hydrazones / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010138:Pacemaker, Artificial; D011724:Pyridazines / Q000627:therapeutic use*; D000077464:Simendan
D000889:Anti-Arrhythmia Agents; D002316:Cardiotonic Agents; D006835:Hydrazones; D011724:Pyridazines; D000077464:Simendan